News

Atara Biotherapeutics Receives FDA Complete Response Letter for EBVALLO Cancer Treatment, Faces Securities Class Action

Oncology - Post-transplant lymphoproliferative disease · 3 min

Novo Nordisk's Oral Ozempic Becomes First FDA-Approved Pill GLP-1 for Type 2 Diabetes with Cardiovascular Protection

FDA · Type 2 diabetes with cardiovascular risk reduction · 3 min

ZETA SURGICAL Receives FDA 510(k) Clearance for Brain Surgery Navigation System

FDA · 2 min

Viatris Presents Six Studies on Low-Dose Estrogen Contraceptive Patch at ACOG 2026

2 min

Axsome Therapeutics Receives FDA Approval for AUVELITY to Treat Alzheimer's Agitation - First-in-Class Breakthrough

FDA · Alzheimer's disease agitation · 3 min

Arvinas Receives FDA Approval for VEPPANU (Vepdegestrant), First PROTAC Drug for ESR1-Mutated Breast Cancer

FDA · Oncology - Breast Cancer · 3 min

Moderna FDA Talks Focus on Phase 4 COVID Vaccine Data

FDA · COVID-19 · 7 min

MRM Health's MH002 Receives FDA Fast Track Designation for Ulcerative Colitis Treatment

FDA · 2 min

Cadrenal Therapeutics CAD-1005 Gets FDA Guidance for Phase 3 Trial in Heparin-Induced Thrombocytopenia

FDA · Hematology/Thrombotic Disorders · 3 min

RedHill's RHB-204 Shows Comparable Efficacy to RHB-104 in Crohn's Disease MAP Treatment Development

2 min

Phathom Pharmaceuticals VOQUEZNA Sales Surge 104% in Q1 2026, Company Maintains Profitability Guidance

2 min

Contineum Therapeutics PIPE-791 Shows Positive Phase 1b Results for Chronic Osteoarthritis Pain

2 min